Terms: = Head and neck cancer AND WHSC1L1, ENSG00000147548, 54904
3 results:
1. whsc1l1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer.
Saloura V; Vougiouklakis T; Zewde M; Deng X; Kiyotani K; Park JH; Matsuo Y; Lingen M; Suzuki T; Dohmae N; Hamamoto R; Nakamura Y
Sci Rep; 2017 Jan; 7():40664. PubMed ID: 28102297
[TBL] [Abstract] [Full Text] [Related]
2. whsc1l1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck.
Saloura V; Vougiouklakis T; Zewde M; Kiyotani K; Park JH; Gao G; Karrison T; Lingen M; Nakamura Y; Hamamoto R
Oncotarget; 2016 Jul; 7(27):42527-42538. PubMed ID: 27285764
[TBL] [Abstract] [Full Text] [Related]
3. Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.
Mariano FV; Giovanetti K; Saccomani LF; Del Negro A; Kowalski LP; Krepischi AC; Altemani A
Braz J Otorhinolaryngol; 2016; 82(6):687-694. PubMed ID: 26971045
[TBL] [Abstract] [Full Text] [Related]
